U.S. FDA Gets Tougher With Certain Drug Trials; Limiting Use of "Non-inferiority" Clinical Trials
Pharmalot -- Just how useful are non-inferiority trials? For the uninitiated, such trials compare a drug being developed with one that is already approved by the FDA. Drugmakers, of course, pursue such studies so they can show their new med is no worse than another, and may even show some benefits.